Drug Information

Drug General Information
Drug ID
D09HFJ
Former ID
DIB005383
Drug Name
NM-3
Drug Type
Small molecular drug
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [521536]
Company
Genzyme
Formula
C13H12O6
Canonical SMILES
CC(C1=CC2=CC(=CC(=C2C(=O)O1)O)OC)C(=O)O
InChIKey
BPZCXUROMKDLGX-UHFFFAOYSA-N
CAS Number
CAS 181427-78-1
PubChem Compound ID
5493470
PubChem Substance ID
11694644, 14823856, 39475206, 57364792, 78836418, 114001061, 125678626, 127551425, 134223962, 135134777, 137071769, 142130963, 162806188, 229230001, 252215914
Target and Pathway
Target(s) VEGF ligand Target Info Inhibitor [528167]
References
Ref 521536ClinicalTrials.gov (NCT00046696) A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.. U.S. National Institutes of Health.
Ref 5281672-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. Diabetes. 2006 May;55(5):1232-42.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.